Calydon, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Calydon, Inc. - overview
Established
1994
Location
Sunnyvale, CA, US
Primary Industry
Pharmaceuticals
About
Calydon is a gene therapy company focused on the development and commercialization of cancer vaccines and gene therapies to treat major, life-threatening diseases.
Current Investors
Sequoia, Perseus
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Verticals
Manufacturing
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Calydon, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.